help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2006-2093
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chamarthi, B.
Right arrow Articles by Williams, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chamarthi, B.
Right arrow Articles by Williams, G. H.
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Cardiovascular Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 4 1340-1346
Copyright © 2007 by The Endocrine Society

Urinary Free Cortisol: An Intermediate Phenotype and a Potential Genetic Marker for a Salt-Resistant Subset of Essential Hypertension

Bindu Chamarthi, Nikheel S. Kolatkar, Steven C. Hunt, Jonathan S. Williams, Ellen W. Seely, Nancy J. Brown, Laine J. Murphey, Xavier Jeunemaitre and Gordon H. Williams

Division of Endocrinology, Diabetes, and Hypertension (B.C., N.S.K., J.S.W., E.W.S., G.H.W.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115; Cardiovascular Genetics Division (S.C.H.), University of Utah School of Medicine, Salt Lake City, Utah 84132; Department of Medicine (N.J.B., L.J.M.), Vanderbilt University Medical Center, Nashville, Tennessee 37232; and Department de Genetique (X.J.), Hôpital Européen Georges Pompidou, 75908 Paris, France

Address all correspondence and requests for reprints to: Gordon H. Williams, M.D., Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women’s Hospital, 221 Longwood Avenue, Boston, Massachusetts 02115. E-mail: gwilliams{at}partners.org.

Context: Emerging evidence suggests a role for cortisol in essential hypertension, and preliminary reports indicate that urinary free cortisol (UFC) may be an intermediate phenotype.

Objectives: The objectives of this study were: 1) confirm bimodality of UFC, 2) assess whether UFC variations aggregate in hypertensive families, and 3) compare low-mode and high-mode UFC groups for distinguishing features.

Subjects/Setting: Subjects included 390 hypertensives and 166 normotensives from the general community.

Design/Interventions: Subjects had blood pressure and laboratory measurements on high- and low-salt diets. Familial aggregation was evaluated in 250 hypertensive siblings from 117 families.

Results: Hypertensives had higher UFC than normotensives (P < 0.001) and bimodal distribution of UFC (P < 0.0001). Analyses were controlled for gender and dietary sodium, which are confounding determinants of UFC. Mean low-mode UFC (33.8 ± 10.6 µg per 24 h) was similar to that of normotensives. The high mode, comprising 31.3% of hypertensives, had less change in mean arterial pressure between diets than the low mode (P = 0.01) without any other significant differences. Observed proportions of concordance and discordance for UFC mode differed significantly from that expected (P < 0.001). Observed concordance for the high mode was twice that expected, whereas for the low mode, it was similar to that expected by chance. Family membership explained a significant proportion of variance in UFC classification (P = 0.027). UFC mode of one sibling was a significant predictor of the UFC mode of the other sibling [odds ratio 6.6, 95% confidence interval (2.4–18.0), P < 0.001].

Conclusion: High-mode UFC is an intermediate phenotype of hypertension associated with salt resistance and a strong familial component supporting heritability.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
G. Reimondo, S. Bovio, B. Allasino, S. De Francia, B. Zaggia, I. Micossi, A. Termine, F. De Martino, P. Paccotti, F. Di Carlo, et al.
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome
Eur. J. Endocrinol., November 1, 2008; 159(5): 569 - 576.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Commercial assays for urinary free cortisol do not measure cortisol accurately
Beverley E. Pearson Murphy, et al.
JCEM Online, 22 May 2007 [Full text]
Response to: Commercial assays for urinary free cortisol do not measure cortisol accurately
Bindu Chamarthi, et al.
JCEM Online, 22 May 2007 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society